Skip to main content

Want a detailed portfolio tracker?

Revolution Medicines (RVMD) Income Statement (2019 - 2026)

Income Statement report data from Mar 31, 2019 to Mar 31, 2026 for Revolution Medicines (RVMD).

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

Reported currency: USD
Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019
Revenue and COGS
Total Revenue
---------740K-3.82M
(-45.51%)
7.01M
(-54.27%)
15M
(+356.25%)
3.36M
(-63.16%)
9.12M
(+20.32%)
7.58M
(-19.87%)
9.46M
(+760.00%)
1.10M
(-87.36%)
8.70M
(-14.12%)
10M
(+15.77%)
8.75M
(-30.88%)
13M
(+26.22%)
10M
(-13.16%)
12M
(-4.47%)
12M
(-3.36%)
13M
(+1.87%)
12M
(-6.76%)
13M
Operating Expenses
Research And Development
344M
(+16.62%)
295M
(+12.35%)
263M
(+17.12%)
224M
(+8.93%)
206M
(+9.72%)
188M
(+23.57%)
152M
(+12.47%)
135M
(+14.33%)
118M
(-20.51%)
148M
(+37.81%)
108M
(+9.96%)
98M
(+42.10%)
69M
(+4.26%)
66M
(-4.79%)
69M
(+13.87%)
61M
(+7.98%)
56M
(+5.23%)
54M
(+15.52%)
46M
(+1.15%)
46M
(+12.43%)
41M
(+10.40%)
37M
(+6.14%)
35M
(+5.92%)
33M
(+19.88%)
27M
(-0.11%)
27M
(+19.73%)
23M
(+14.12%)
20M
(-5.05%)
21M
Selling General And Administrative
101M
(+51.84%)
67M
(+26.38%)
53M
(+30.01%)
41M
(+15.91%)
35M
(+21.60%)
29M
(+20.16%)
24M
(+10.36%)
22M
(-4.95%)
23M
(-29.16%)
32M
(+107.87%)
16M
(+5.94%)
15M
(+10.74%)
13M
(+21.17%)
11M
(+4.60%)
10M
(+2.25%)
10M
(+12.83%)
9.04M
(+4.03%)
8.69M
(+11.55%)
7.79M
(+6.71%)
7.30M
(+9.45%)
6.67M
(+14.41%)
5.83M
(+9.18%)
5.34M
(+4.91%)
5.09M
(-1.55%)
5.17M
(+24.28%)
4.16M
(+34.19%)
3.10M
(+13.55%)
2.73M
(+12.81%)
2.42M
Operating Expenses
445M
(+23.11%)
362M
(+14.70%)
315M
(+19.10%)
265M
(+9.95%)
241M
(+11.30%)
216M
(+23.11%)
176M
(+12.17%)
157M
(+11.20%)
141M
(-22.06%)
181M
(+46.64%)
123M
(+9.44%)
113M
(+37.06%)
82M
(+6.66%)
77M
(-3.57%)
80M
(+12.19%)
71M
(+8.67%)
66M
(+5.07%)
62M
(+14.95%)
54M
(+1.93%)
53M
(+11.99%)
48M
(+10.97%)
43M
(+6.52%)
40M
(+5.79%)
38M
(+16.49%)
33M
(+3.10%)
32M
(+21.40%)
26M
(+14.14%)
23M
(-3.22%)
24M
Depreciation And Amortization
2.20M
(+4.76%)
2.10M
(+5.00%)
2.00M
(+17.65%)
1.70M
(+6.25%)
1.60M
(+6.67%)
1.50M
(-6.25%)
1.60M
(0.00%)
1.60M
(+6.67%)
1.50M
(+15.38%)
1.30M
(0.00%)
1.30M
(+8.33%)
1.20M
(-0.83%)
1.21M
(+3.42%)
1.17M
(+17.00%)
1.00M
(+11.11%)
900K
(0.00%)
900K
(+11.11%)
810K
(+1.25%)
800K
(0.00%)
800K
(+19.40%)
670K
(-1.47%)
680K
(-2.86%)
700K
(+16.67%)
600K
(-4.76%)
630K
(-3.08%)
650K
(+8.33%)
600K
(+20.00%)
500K
(-5.66%)
530K
Operating Income
Operating Income
-445.22M
(+23.11%)
-361.63M
(+14.70%)
-315.27M
(+19.10%)
-264.71M
(+9.95%)
-240.76M
(+11.30%)
-216.31M
(+23.11%)
-175.71M
(+12.17%)
-156.64M
(+11.20%)
-140.86M
(-21.74%)
-179.98M
(+46.03%)
-123.25M
(+13.28%)
-108.80M
(+44.76%)
-75.16M
(+21.80%)
-61.71M
(-19.36%)
-76.53M
(+23.26%)
-62.09M
(+7.14%)
-57.95M
(+9.53%)
-52.91M
(-0.47%)
-53.16M
(+19.38%)
-44.53M
(+19.06%)
-37.40M
(+9.74%)
-34.08M
(+23.70%)
-27.55M
(-1.54%)
-27.98M
(+32.73%)
-21.08M
(+7.77%)
-19.56M
(+44.25%)
-13.56M
(+28.41%)
-10.56M
(+1.15%)
-10.44M
Ebit
-445.22M
(+23.11%)
-361.63M
(+14.70%)
-315.27M
(+19.10%)
-264.71M
(+9.95%)
-240.76M
(+11.30%)
-216.31M
(+23.11%)
-175.71M
(+12.17%)
-156.64M
(+11.20%)
-140.86M
(-21.74%)
-179.98M
(+46.03%)
-123.25M
(+13.28%)
-108.80M
(+44.76%)
-75.16M
(+21.80%)
-61.71M
(-19.36%)
-76.53M
(+23.26%)
-62.09M
(+7.14%)
-57.95M
(+9.53%)
-52.91M
(-0.47%)
-53.16M
(+19.38%)
-44.53M
(+19.06%)
-37.40M
(+9.74%)
-34.08M
(+23.70%)
-27.55M
(-1.54%)
-27.98M
(+32.73%)
-21.08M
(+7.77%)
-19.56M
(+44.25%)
-13.56M
(+28.41%)
-10.56M
(+1.15%)
-10.44M
EBITDA
-443.02M
(+23.22%)
-359.53M
(+14.77%)
-313.27M
(+19.11%)
-263.01M
(+9.97%)
-239.16M
(+11.34%)
-214.81M
(+23.38%)
-174.11M
(+12.30%)
-155.04M
(+11.25%)
-139.36M
(-22.01%)
-178.69M
(+46.53%)
-121.95M
(+13.34%)
-107.60M
(+45.50%)
-73.95M
(+22.15%)
-60.54M
(-19.85%)
-75.53M
(+23.44%)
-61.19M
(+7.26%)
-57.05M
(+9.50%)
-52.10M
(-0.50%)
-52.36M
(+19.73%)
-43.73M
(+19.06%)
-36.73M
(+9.97%)
-33.40M
(+24.39%)
-26.85M
(-1.94%)
-27.38M
(+33.89%)
-20.45M
(+8.09%)
-18.92M
(+45.99%)
-12.96M
(+28.83%)
-10.06M
(+1.51%)
-9.91M
Other Income / Expenses
Interest Income
20M
(-8.36%)
21M
(-3.58%)
22M
(-1.43%)
22M
(-10.11%)
25M
(+17.38%)
21M
(+4.02%)
20M
(-5.03%)
21M
(-9.55%)
24M
(+25.18%)
19M
(+73.33%)
11M
(+4.29%)
11M
(+48.73%)
7.06M
(+38.98%)
5.08M
(+74.57%)
2.91M
(+234.48%)
870K
(+190.00%)
300K
(+25.00%)
240K
(+9.09%)
220K
(-8.33%)
240K
(+4.35%)
230K
(-8.00%)
250K
(-28.57%)
350K
(-52.05%)
730K
(-19.78%)
910K
(+46.77%)
620K
(-19.48%)
770K
(+63.83%)
470K
(+38.24%)
340K
Interest Expense
12M
(-4.69%)
13M
(+11.99%)
11M-----------------10K
(0.00%)
10K
(-50.00%)
20K
(0.00%)
20K
(0.00%)
20K
(-81.82%)
110K---
Net Interest Income
20M
(-8.36%)
21M
(-3.58%)
22M
(-1.43%)
22M
(-10.11%)
25M
(+17.38%)
21M
(+4.02%)
20M
(-5.03%)
21M
(-9.55%)
24M
(+25.18%)
19M
(+73.33%)
11M
(+4.29%)
11M
(+48.73%)
7.06M
(+38.98%)
5.08M
(+74.57%)
2.91M
(+234.48%)
870K
(+190.00%)
300K
(+25.00%)
240K
(+9.09%)
220K
(-8.33%)
240K
(+9.09%)
220K
(-8.33%)
240K
(-27.27%)
330K
(-53.52%)
710K
(-20.22%)
890K
(+74.51%)
510K
(-33.77%)
770K
(+63.83%)
470K
(+38.24%)
340K
Other Non Operating Income
120K
(-99.77%)
51M-17M-10.00K89M
(+31571.43%)
280K
(+1300.00%)
20K-2.81M47M--7.06M
(-22.84%)
9.15M
(+214.43%)
2.91M
(+234.48%)
870K
(+190.00%)
300K
(-67.39%)
920K
(+318.18%)
220K
(-8.33%)
240K
(+9.09%)
220K
(-89.86%)
2.17M
(+557.58%)
330K
(-53.52%)
710K
(-20.22%)
890K
(-57.21%)
2.08M
(+181.08%)
740K
(+68.18%)
440K
(+41.94%)
310K
Net Income
Income Before Tax
-453.82M
(+24.37%)
-364.89M
(+19.55%)
-305.21M
(+23.17%)
-247.79M
(+16.10%)
-213.42M
(+9.27%)
-195.32M
(+24.97%)
-156.29M
(+17.31%)
-133.23M
(+14.85%)
-116.00M
(-28.04%)
-161.19M
(+43.54%)
-112.30M
(+14.24%)
-98.30M
(+44.35%)
-68.10M
(+20.25%)
-56.63M
(-23.09%)
-73.63M
(+20.27%)
-61.22M
(+6.19%)
-57.65M
(+9.43%)
-52.68M
(-0.49%)
-52.94M
(+19.50%)
-44.30M
(+19.15%)
-37.18M
(+9.87%)
-33.84M
(+24.32%)
-27.22M
(-0.18%)
-27.27M
(+35.07%)
-20.19M
(+6.43%)
-18.97M
(+47.97%)
-12.82M
(+26.68%)
-10.12M
(-0.10%)
-10.13M
Income Tax Expense
------750.00K---340K-3.87M---120.00K
(-60.00%)
-300.00K------360K--60.00K
(-91.04%)
-670.00K
(-84.67%)
-4.37M---
Net Income From Continuing Operations
-453.82M
(+24.37%)
-364.89M
(+19.55%)
-305.21M
(+23.17%)
-247.79M
(+16.10%)
-213.42M
(+9.69%)
-194.57M
(+24.49%)
-156.29M
(+17.31%)
-133.23M
(+14.85%)
-116.00M
(-28.19%)
-161.54M
(+48.98%)
-108.43M
(+10.31%)
-98.30M
(+44.35%)
-68.10M
(+20.51%)
-56.51M
(-22.94%)
-73.33M
(+19.78%)
-61.22M
(+6.19%)
-57.65M
(+9.43%)
-52.68M
(-0.49%)
-52.94M
(+19.50%)
-44.30M
(+19.15%)
-37.18M
(+8.71%)
-34.20M
(+25.64%)
-27.22M
(+0.04%)
-27.21M
(+39.40%)
-19.52M
(+33.70%)
-14.60M
(+13.88%)
-12.82M
(+26.68%)
-10.12M
(-0.10%)
-10.13M
Net Income
-453.82M
(+24.37%)
-364.89M
(+19.55%)
-305.21M
(+23.17%)
-247.79M
(+16.10%)
-213.42M
(+9.69%)
-194.57M
(+24.49%)
-156.29M
(+17.31%)
-133.23M
(+14.85%)
-116.00M
(-28.19%)
-161.54M
(+48.98%)
-108.43M
(+10.31%)
-98.30M
(+44.35%)
-68.10M
(+20.51%)
-56.51M
(-22.94%)
-73.33M
(+19.78%)
-61.22M
(+6.19%)
-57.65M
(+9.43%)
-52.68M
(-0.49%)
-52.94M
(+19.50%)
-44.30M
(+19.15%)
-37.18M
(+8.71%)
-34.20M
(+25.64%)
-27.22M
(+0.04%)
-27.21M
(+39.40%)
-19.52M
(+33.70%)
-14.60M
(+13.88%)
-12.82M
(+26.68%)
-10.12M
(-0.10%)
-10.13M
Comprehensive Income Net Of Tax
-457.67M
(-59.48%)
-1.13B
(+272.25%)
-303.39M
(+22.24%)
-248.19M
(+16.50%)
-213.03M
(-64.45%)
-599.32M
(+297.93%)
-150.61M
(+12.48%)
-133.90M
(+13.73%)
-117.74M
(-72.87%)
-434.04M
(+301.70%)
-108.05M
(+9.15%)
-98.99M
(+48.03%)
-66.87M
(-73.26%)
-250.11M
(+238.08%)
-73.98M
(+19.90%)
-61.70M
(+5.38%)
-58.55M
(-68.79%)
-187.58M
(+253.99%)
-52.99M
(+19.48%)
-44.35M
(+19.12%)
-37.23M
(-65.57%)
-108.12M
(+296.04%)
-27.30M
(+1.26%)
-26.96M
(+37.83%)
-19.56M
(-58.90%)
-47.59M
(+273.25%)
-12.75M
(+25.86%)
-10.13M
(0.00%)
-10.13M